Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
Axsome Therapeutics (AXSM) Stock Price & Analysis
1,415 Followers
AXSM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$20.63 - $82.00
Previous Close$74.29
Volume1.91M
Average Volume (3M)1.27M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$227.52M
Total Debt (Recent Filing)$94.33M
Price to Earnings (P/E)-18.3
Beta0.39
Next EarningsFeb 27, 2023
EPS Estimate-$1.12
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$109.30
EPS (TTM)-4.07
Shares Outstanding43,426,162
R-Squared0.06
Standard Deviation0.41
10 Day Avg. Volume808,803
30 Day Avg. Volume1,268,101
Price to Book (P/B)38.68
Price to Sales (P/S)126.09
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-22.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside59.10% Upside
Rating ConsensusStrong Buy
Alpha0.10
Number of Analyst Covering11
Axsome Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AXSM FAQ
What was Axsome Therapeutics’s price range in the past 12 months?
Axsome Therapeutics lowest stock price was $20.63 and its highest was $82.00 in the past 12 months.
What is Axsome Therapeutics’s market cap?
Currently, no data Available
When is Axsome Therapeutics’s upcoming earnings report date?
Axsome Therapeutics’s upcoming earnings report date is Feb 27, 2023 which is in 23 days.
How were Axsome Therapeutics’s earnings last quarter?
Axsome Therapeutics released its earnings results on Nov 07, 2022. The company reported -$1.07 earnings per share for the quarter, missing the consensus estimate of -$1.05 by -$0.02.
Is Axsome Therapeutics overvalued?
According to Wall Street analysts Axsome Therapeutics’s price is currently Undervalued.
Does Axsome Therapeutics pay dividends?
Axsome Therapeutics does not currently pay dividends.
What is Axsome Therapeutics’s EPS estimate?
Axsome Therapeutics’s EPS estimate is -$1.12.
How many shares outstanding does Axsome Therapeutics have?
Axsome Therapeutics has 43,426,163 shares outstanding.
What happened to Axsome Therapeutics’s price movement after its last earnings report?
Axsome Therapeutics reported an EPS of -$1.07 in its last earnings report, missing expectations of -$1.05. Following the earnings report the stock price went down -0.473%.
Which hedge fund is a major shareholder of Axsome Therapeutics?
Among the largest hedge funds holding Axsome Therapeutics’s share is Fairmount Funds Management Llc. It holds Axsome Therapeutics’s shares valued at 85M.
---
Axsome Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$109.30
$109.30
Blogger Sentiment
Bullish
AXSM Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 954.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $22.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
154.16%
12-Months-Change
Fundamentals
Return on Equity
-159.81%
Trailing 12-Months
Asset Growth
190.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Axsome Therapeutics Inc
Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
---
Elanco Animal Health
―
Harmony Biosciences Holdings
―
Prestige Consumer Healthcare
―
Intra-Cellular Therapies
―
---